SpIntellx Inc. presented a poster at the American Association of Cancer Research (AACR) Annual Meeting on April 1, 2019, that demonstrates predictions of the risk of relapse in a pilot study of colon cancer over five years. SpIntellx is a computational and systems pathology company applying its proprietary explainable...